FR EN
Share this page

Delphine BADINAND

MD

    Onco-radiotherapist at the Timone Hospital

APHM

MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

Cancerology is booming and immunotherapy represents the most promising approach. At the APHM we have been at the forefront of these therapeutic advances and as a radiotherapist, I’m developing new strategies combining radiotherapy and immunotherapy to reach the « abscopal effect ». MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.

#clinic 

Have a look on our testimonies

MI COMMUNITY
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.

Jacques PFISTER
CCI Marseille Provence
MI COMMUNITY
Cell- and tissue- based therapies and gene therapies hold great promise in the field of both immunotherapy and regenerative medicine.

Christian CHABANNON
AMU, IPC, AP-HM, Inserm
MI COMMUNITY
HalioDx is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.

Vincent FERT
HALIODX
MI COMMUNITY
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .

Nicolas SCHLEINITZ
AP-HM, AMU
MI AND YOU Show
your commitment to MI